Chemotherapy improves low performance status lung cancer patients Source: Eur Respir J 2007; 30: 1186-1192 Year: 2007
Correlation between parameters of quality of life in patients with non-small cell lung cancer treated by chemotherapy and radiotherapy Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007
Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 752s Year: 2006
Systematic review of the effect of chemotherapy on quality of life (QoL) and symptom control in patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2006 - Lung cancer treatment Year: 2006
Correlation of quality of life parameters with parameters of health state in patients with nonsmall cell lung cancer treated by chemotherapy Source: Eur Respir J 2003; 22: Suppl. 45, 30s Year: 2003
Measurement of individual quality of life in patients with lung cancer receiving palliative chemotherapy Source: Eur Respir J 2003; 22: Suppl. 45, 432s Year: 2003
Quality of life assessment in advanced stage of lung cancer patients before and after chemotherapy Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
Effects of chemotherapy on quality of life for patients with lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 327s Year: 2005
Assessment of lung function and quality of life in patients submitted to lung resection for cancer Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery Year: 2008
Comparisson of lung function tests parameters and dyspnoea score by EORTC quality of life questionnaire C30 in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 74s Year: 2004
Functional status measures related to quality of life in patients with lung cancer Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012
Symptom control in advanced non-small cell lung cancer (NSCLC): what is the influence of cisplatin-use, age, performance status and duration of chemotherapy? Analysis of a randomized database Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002
Comparison of quality of life in patients with non-small cell lung cancer treated by chemotherapy or radiotherapy Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004
Observations on quality of life assessments using functional assessment of cancer-Lung (FACT-L) in patients under lung cancer chemotherapy. Ongoing study Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010
Assessment of psychological distress in patients with lung cancer receiving palliative chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005
Performance status as predictor factor of quality of life in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004
Interstitial lung disease associated by gemcitabine chemotherapy in non-small lung cancer patients: Analysis based on the data in practical use with confirmed denominator Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011
Quality of life in patients with advanced forms of NSCLC and breast cancer after induction chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Should patients with metastatic NSCLC and poor performance status be treated by chemotherapy? Source: Annual Congress 2007 - Treatment of metastatic nonsmall cell lung cancer in the era of targeted therapies Year: 2007
A variant in LKB1 gene can predicts the clinical outcomes of chemotherapy in patients with non-small cell lung cancer Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management Year: 2018